| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
and 
1
* Department of Biological Chemistry, Graduate School of Pharmaceutical Sciences, and
School of Health Sciences, Faculty of Medicine, Kyoto University, Kyoto, Japan;
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tokyo, Japan; and
Research Center for Glycobiotechnology, Ritsumeikan University, Shiga, Japan
Mannan-binding protein (MBP) is a C-type serum lectin that is known to be a host defense factor involved in innate immunity, and recognizes mannose, fucose, and N-acetylglucosamine residues. Although some exogenous MBP ligands have been reported, little is known about its endogenous ligands. In the present study, we found that endogenous MBP ligands are highly expressed in the brush border epithelial cells of kidney-proximal tubules by immunohistochemistry, and both meprin 
and 
(meprins), as novel endogenous MBP ligands, have been identified through affinity chromatography and mass spectrometry. Meprins are membrane-bound and secreted zinc metalloproteases extensively glycosylated and highly expressed in kidney and small intestinal epithelial cells, leukocytes, and certain cancer cells. Meprins are capable of cleaving growth factors, extracellular matrix proteins, and biologically active peptides. Deglycosylation experiments indicated that the MBP ligands on meprins are high mannose- or complex-type N-glycans. The interaction of MBP with meprins resulted in significant decreases in the proteolytic activity and matrix-degrading ability of meprins. Our results suggest that core N-linked oligosaccharides on meprins are associated with the optimal enzymatic activity and that MBP is an important regulator for modulation of the localized meprin proteolytic activity via N-glycan binding. Because meprins are known to be some of the major matrix-degrading metalloproteases in the kidney and intestine, MBP, which functions as a natural and effective inhibitor of meprins, may contribute, as a potential therapeutic target, to tumor progression by facilitating the migration, intravasation, and metastasis of carcinoma cells, and to acute renal failure and inflammatory bowel diseases.
This article has been cited by other articles:
|
|
 |
|
  R. A. Ramadas, L. Wu, and A. M. LeVine Surfactant Protein A Enhances Production of Secretory Leukoprotease Inhibitor and Protects It from Cleavage by Matrix Metalloproteinases J. Immunol., February 1, 2009; 182(3): 1560 - 1567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Bergin, C. M. Greene, E. E. Sterchi, C. Kenna, P. Geraghty, A. Belaaouaj, C. C. Taggart, S. J. O'Neill, and N. G. McElvaney Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway J. Biol. Chem., November 14, 2008; 283(46): 31736 - 31744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bylander, Q. Li, G. Ramesh, B. Zhang, W. B. Reeves, and J. S. Bond Targeted disruption of the meprin metalloproteinase {beta} gene protects against renal ischemia-reperfusion injury in mice Am J Physiol Renal Physiol, March 1, 2008; 294(3): F480 - F490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Ishmael, F. T. Ishmael, A. D. Jones, and J. S. Bond Protease Domain Glycans Affect Oligomerization, Disulfide Bond Formation, and Stability of the Meprin A Metalloprotease Homo-oligomer J. Biol. Chem., December 8, 2006; 281(49): 37404 - 37415. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
